Assessment of idiopathic dilated cardiomyopathy using positron emission tomography (PET).
暂无分享，去创建一个
[1] M. Phelps,et al. Value of metabolic imaging with positron emission tomography for evaluating prognosis in patients with coronary artery disease and left ventricular dysfunction. , 1994, The American journal of cardiology.
[2] R. Coleman,et al. Human pathologic correlation with PET in ischemic and nonischemic cardiomyopathy. , 1993, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[3] M. Phelps,et al. Differentiating cardiomyopathy of coronary artery disease from nonischemic dilated cardiomyopathy utilizing positron emission tomography. , 1991, Journal of the American College of Cardiology.
[4] J. Poloniecki,et al. Prognostic value of thallium-201 perfusion defects in idiopathic dilated cardiomyopathy. , 1991, The American journal of cardiology.
[5] R. Okada,et al. Value and limitations of radionuclide angiography in determining the cause of reduced left ventricular ejection fraction: comparison of idiopathic dilated cardiomyopathy and coronary artery disease. , 1985, The American journal of cardiology.
[6] E. Henze,et al. Alterations in regional myocardial metabolism, perfusion, and wall motion in Duchenne muscular dystrophy studied by radionuclide imaging. , 1984, Circulation.
[7] G. Pohost,et al. The Influence of Left Ventricular Volume and Wall Motion on Myocardial Images , 1979, Circulation.